Comparative Effectiveness and Safety of Oral Anticoagulants across Kidney Function in Patients with Atrial Fibrillation

BACKGROUND: Patients with atrial fibrillation (AF) and severely decreased kidney function were excluded from the pivotal NOAC trials, thereby raising questions about comparative safety and effectiveness in patients with reduced kidney function. The study aimed to compare oral anticoagulants across t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Cardiovasc Qual Outcomes
Autors principals: Yao, Xiaoxi, Inselman, Jonathan W., Ross, Joseph S., Izem, Rima, Graham, David J., Martin, David B., Thompson, Aliza M., Southworth, Mary Ross, Siontis, Konstantinos C., Ngufor, Che G., Nath, Karl A., Desai, Nihar R., Nallamothu, Brahmajee K., Saran, Rajiv, Shah, Nilay D., Noseworthy, Peter A.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580213/
https://ncbi.nlm.nih.gov/pubmed/33012172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.120.006515
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars